We have mapped the region for the protein interaction site of the Escherichia coli mismatch repair protein MutH for its activator protein MutL by a site-speci®c protein modi®cation approach. For this purpose we generated a cysteine-free variant of MutH and 12 variants thereof, each containing a single cysteine residue at surface positions selected on the basis of available structural and sequence information for MutH. All MutH variants displayed wild type activity both in vivo and in vitro. These variants were then site-speci®cally modi®ed at their cysteine residues with thiol-speci®c reagents and then tested for their ability to be stimulated in their DNA cleavage activity by the activator protein MutL. Thereby we were able to identify a de®ned region in the MutH protein that is important for interaction with MutL, and most likely represents the MutL binding site of MutH.
INTRODUCTION
Correction of replication errors by mismatch repair systems present in most organisms enhances the ®delity of DNA replication by up to a factor of 1000 (1±5). The paradigm of such a system is the MutHLS system from Escherichia coli (6) . Mismatch repair by MutHLS is initiated by binding of a MutS homodimer to the mismatch. After recruitment of MutL, this complex searches for a strand discrimination signal in an ATP-dependent manner. In the case of E.coli, this signal is the transiently unmethylated dam site of the newly replicated daughter strand, which is recognized by the endonuclease MutH. After activation by MutL, MutH cleaves the unmethylated daughter strand (7) and thereby marks it for removal and repair-synthesis involving a variety of other proteins (8) .
Recently, the structures of E.coli MutH (9) , the N-terminal domain of E.coli MutL (10, 11) , and E.coli as well as Thermus aquaticus MutS (12,13) have been determined. The analysis of the crystal structures of MutH revealed three different forms of the MutH protein indicating that there is an inherent conformational¯exibility in the MutH protein (9) . The conformations of MutH that do not have a properly formed catalytic center, therefore, might be transformed into the active conformation upon interaction with MutS and MutL. In vitro, the activation of MutH can occur in a mismatch-dependent manner involving MutS and MutL (14, 15) or in a mismatch-independent manner by MutL alone (11, 16) . Physical interaction between MutH and MutL has been demonstrated by two-hybrid assays (16, 17) , by the ability of MutH to bind to a MutL column (16) as well as by the MutL-mediated binding of MutH to a MutS column (18) . The mechanism of activation by MutL involves stimulation of both DNA binding and cleavage by MutH (19) . Models for the complex of MutHLS have been proposed (12, 20) . However, the protein±protein interaction sites have not been veri®ed experimentally so far. It has been proposed that the non-conserved C-terminal tail of MutH is important for the interaction with MutL (9) . However, deletion of the last ®ve amino acid residues of MutH did not affect its function in vivo and in vitro (21) . Moreover, complementation of a mutH ± mutator phenotype in E.coli by MutH from related bacteria indicated that the non-conserved C-terminal tail of MutH is unlikely to be the interaction site for MutL (22) . Hence, the interaction site of MutH for MutL remains elusive.
In order to identify the MutL binding site of MutH, we used a mapping strategy in which single amino acid residues on the surface of MutH were changed to cysteine residues and, after site-speci®c modi®cation of these cysteines with maleimide derivatives of different size, we determined whether the modi®cations disrupted activation of MutH by MutL. Similar strategies have already been successfully used for the mapping of the binding interaction between gp45 and gp44/62 (23) and the sonic hedgehog±receptor interaction (24) . It has advantages over other mapping strategies, e.g. alanine scanning mutagenesis, not relying on the exact identi®cation of hot spots in binding interfaces (25) and should be applicable for the mapping of the MutL±MutS interaction as well.
MATERIALS AND METHODS

Plasmids and reagents
Escherichia coli K12 strains CC106 {P90C [araD(lacpro)XIII F ¢lacIZ proB + ]} (26), TX2928 (CC106 but mutH471::Tn5;Kan r ) (27) and the pET-15b (Novagen) derived plasmids pTX417 and pTX418 containing the mutH and mutL genes, respectively, under control of the T7 promotor were kindly provided by Dr M. Winkler (27) . Plasmid pMQ402 (His 6 -MutH), a pBAD18 derivative, was a kind gift of Dr M. Marinus (21) . For protein expression, the E.coli strains HMS174(lDE3) from Novagen and XL1 blue MRF ¢ from Stratagene were used. The E.coli strain JM110 (rpsL (Str r ) thr leu thi-1 lacY galK galT ara tonA tsx dam dcm supE44 D(lac-proAB) [F¢ traD36 proAB lacI q Z D M15] (28) was used for preparation of the unmethylated plasmid pUC8 (29) . Luria±Bertani (LB) medium (1 l) was made with 10 g tryptone, 5 g yeast extract, 5 g NaCl and 1 mM NaOH. Ampicillin, kanamycin and rifampicin were added to the media at a ®nal concentration of 75, 25 and 100 mg/ml, respectively.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using a modi®cation of the Quikchange protocol (Stratagene) (30) essentially as described before using the plasmid pMQ402 as template (31) . Escherichia coli XL1-blue MRF ¢ were transformed with the full-length PCR product. Marker positive clones were inoculated in LB medium containing ampicillin for overnight growth. Plasmid DNA was isolated using the QIAprep Spin Miniprep (Qiagen) and the whole mutH gene was sequenced.
Complementation of a mutH mutator phenotype
The complementation assay is based on the mutator phenotype, which becomes apparent when E.coli lacks MutH. The mutation phenotype is monitored by the frequency of mutations in the polB gene, causing resistance to rifampicin (21) . Single colonies of CC106 (wild type) or TX2928 (mutH ± ) transformed with the indicated plasmids were grown in 3 ml LB cultures containing 100 mg/ml ampicillin, overnight at 37°C. Aliquots of 50 ml from the undiluted or 10 ±6 diluted culture were plated on LB agar containing 25 mg/ ml ampicillin with or without 100 mg/ml rifampicin, respectively. Colonies were counted after overnight incubation at 37°C.
Puri®cation of recombinant MutH, MutL and MutS proteins
Recombinant His 6 -tagged MutH and MutL proteins were expressed in XL1 blue MRF ¢ and HMS174(lDE3), respectively, and puri®ed by Ni-NTA chromatography essentially as described before (27, 31) . Protein concentrations were determined using the theoretical extinction coef®cients (32) .
Site-speci®c protein modi®cation
The following thiol-speci®c reagents were used: N-ethylmaleimide (NEM, M r = 125.1) and benzophenone-4-maleimide (M r = 277.3) were from Sigma,¯uorescein-5-maleimide (M r = 498.4) was from Molecular Probes and mPEG-MAL (M r = 5000) was from Shearwater Polymers, Inc. (Fig. 1) . Stock solutions of NEM and mPEG-MAL were prepared in water, of benzophenone-4-maleimide and¯uorescein-5-maleimide in dimethylformamide. For modi®cation MutH at a concentration of 10±50 mM protein was incubated in 20 mM HEPES, pH 6.5, 200 mM NaCl for 30 min at room temperature with a 2-to 100-fold molar excess of maleimide reagent. Reactions were stopped by adding a 5-fold molar excess of DTT over maleimide reagent for 10 min at room temperature. The extent of modi®cation in experiments with varying excess of modi®cation reagent over protein was monitored by SDS±PAGE followed by¯uorescence imaging in the case of¯uorescein-5-maleimide modi®cation or Coomassie staining in the case of mPEG-MAL. The extent of modi®cation by NEM was controlled by inhibition of subsequent modi®cation with excess¯uoresceine-5-maleimide. All but the benzophenone-4-maleimide modi®ed proteins were puri®ed from excess reagent and, in the case of the PEG modi®cation from unmodi®ed protein, by gel ®ltration on a Superdex75 column.
MutH endonuclease assay
Endonuclease activity of MutH proteins was determined by analyzing the cleavage of unmethylated plasmid pUC8. MutH (50 nM) was incubated with 20 ng/ml pUC8 in 10 mM Tris±HCl, pH 7.5, 10 mM MgCl 2 , 0.75 mM ATP and 0.05 mg/ml bovine serum albumin at 37°C in the presence of either 10% DMSO or 2 mM E.coli MutL. Cleavage reactions were stopped by removing 10-ml aliquots from the reaction mixture and adding 2 ml of 250 mM EDTA, pH 8.0, 25% sucrose, 0.1% bromphenol blue and 0.1% xylene cyanol. The reaction products were analyzed by 1.2% agarose gel electrophoresis. The ethidium bromide-stained gels were analyzed with a video documentation system (Bio-Rad). The intensity of the stained DNA bands was quanti®ed using the program Total Lab (Phoretix). Initial rates were calculated from the disappearance of the supercoil form of the plasmid and the appearance of the open circular and linear forms of the plasmid, respectively.
Site-speci®c UV crosslinking
For cross-linking studies MutH variants were modi®ed with benzophenone-4-maleimide as described above. Modi®ed variants were incubated at 5 mM with 5 mM MutL in 20 mM Tris±HCl, 5 mM MgCl 2 , 1 mM ATP on ice and then kept in the dark or irradiated at 354 nm with a handheld UV lamp for 20 min. Samples were then subjected to SDS±PAGE analysis.
RESULTS
Strategy for site-directed protein modi®cation
Strategies for mapping protein interaction sites fall into three broad categories: cross-linking, protection and interference (33) . We chose a strategy that in principle allows performing any of these approaches in a site-directed manner and show here our results for an interference analysis. First, we generated a cysteine-free variant of MutH by changing the single non-conserved Cys-96 to serine. This variant was active both in vivo and in vitro indicating that the sulfhydryl group is not important for function (Tables 1 and 2 ). Next, we used the alignment of all available MutH sequences and the structural information for E.coli MutH to identify potential surface residues that could serve as targets for modi®cation. Ten strategically positioned sites were selected for an initial study. None of these residues is conserved in the MutH protein family, and together they cover the entire surface of the molecule. After the results of this ®rst study (see below) two additional sites were selected, Val-166 and Leu-167, which are conserved in the MutH proteins. The positions of the residues on the surface of the MutH protein are shown in Figure 2 . Together these 12 residues cover 9% of the total protein surface.
Single cysteine variants of MutH are active in vivo and in vitro
A prerequisite for the mapping study is that the mutation is not affecting the function of the protein. In rare cases, the mutation directly identi®es the protein±protein interface. Such residues are called`hot spots', since they are of key importance for complex formation (25, 34) . We, therefore, tested MutH variants ®rst for their in vivo function in mismatch repair. All variants were able to complement a mutH mutator phenotype ( Table 1 ). The results indicate that none of the mutated residues is a hot spot for the function in mismatch repair and, thus, also for the interaction with MutL. Subsequently, the proteins were puri®ed and tested for their ability to cleave unmethylated plasmid DNA in the presence of 10% DMSO. It should be noted that the endonuclease activity of MutH in the presence of 10% DMSO is~10-fold higher than in its absence, a phenomenon which is well known for many restriction endonucleases (35) . In the absence of MutL, some of the unmodi®ed MutH variants (u) showed a signi®cantly reduced endonuclease activity (k u D ) compared to the wild type MutH protein (Table 2 ). For example the variants H115C;C96S and S145C;C96S have <10% activity compared with the C96S variant. However, in the presence of the activator protein MutL all variants displayed a near wild type activity (k u L ). This indicates that some mutation might affect the conformational equilibrium between the inactive and active forms of MutH but that this effect can be overcome by the MutL-stimulation, which might have a chaperone-like function on MutH. Note that MutL is structurally related to the chaperone Hsp90 (11) . In summary, all variants show a stimulation in endonuclease activity (k 
Site-speci®c modi®cation of MutH single cysteine variants
We modi®ed the MutH variants with thiol-speci®c reagents ranging in size from <0.4 nm (NEM),~1 nm (¯uorescein-5-maleimide) up to 5 nm (mPEG-MAL 5000), based on the hydrodynamic radius of mPEG-MAL 5000) (Fig. 1) . The extent of modi®cation was monitored by SDS±PAGE and uorescence imaging or Coomassie staining and proved to be >90% at ratios of reagent:protein >5-fold (NEM and uoresceine-5-maleimide) or >25-fold (mPEG-MAL) (Fig. 3) . In the case of the MutH variants S104C;C96S and S145C;C96S a 100-fold excess of modi®cation reagent over protein was needed to achieve >90% modi®cation (data not shown). The modi®ed proteins were puri®ed from excess reagent by gel ®ltration chromatography. In the case of the PEG-modi®ed MutH variants we were able to separate the modi®ed from unmodi®ed variants since the PEG modi®cation (R h = 2.7 nm, M r app = 29 000) almost doubles M r app of the modi®ed variants (R h = 3.3 nm, M r app = 56 000) compared to the unmodi®ed variants (R h = 2.4 nm, M r app = 23 000) (Fig. 4A) . The pegylated proteins were >95% pure as checked by SDS±PAGE (Fig. 4B) .
Endonuclease activity of modi®ed MutH single cysteine variants
We determined the endonuclease activity in the presence of DMSO but in the absence of the activator protein MutL (k
in order to check whether the modi®cation has changed the catalytic activity of the modi®ed MutH variants per se. Interestingly, the pegylated variants fall into different classes (see Table 3 when investigating the effect of the modi®cation in the MutLstimulated endonuclease activity of the modi®ed MutH variants. Subsequently, we determined the MutL-stimulated cleavage activity of the modi®ed MutH variants
. None of the modi®ed variants showed a signi®cantly increased MutL-stimulated cleavage activity compared to the unmodi®ed variants. About half of the modi®ed MutH variants did not show any changes in MutLstimulated cleavage activity upon modi®cation with Nethylmaleimide,¯uorescein-5-maleimide or mPEG-MAL 5000 indicating that these sites of the protein are unlikely to be part of the MutH±MutL interface. However, the variants S104C;C96S, V166C;C96S or L167C;C96S showed a reduction in MutL stimulation upon modi®cation with
, respectively, compared with the unmodi®ed variants.
Structure±activity map of modi®ed MutH variants
We represented the activity data on the surface of the MutH protein (Fig. 5 ) in order to obtain a structure±activity relationship (SAR). It is obvious that all residues which upon modi®cation show a strong reduction in MutL-stimulated endonuclease activity (e.g., k u L ak PEG L b 10) cluster in one region of the protein surface. This suggests that, based on our steric interference analysis, the MutL interface of MutH is located in this area of the protein.
A comparison of the structure±activity map with an evolutionary trace map of the MutH branch of the MutH/ Sau3AI sequence family reveals that several conserved residues cluster in the proposed interaction region (data not shown). Notably one of these residues is Leu-167. The variant L167C;C96S was one of the most severely affected variants in MutL-stimulation upon modi®cation with either¯uorescein-5-maleimide or mPEG-MAL. This further supports our proposition that this area represents the MutH±MutL interface of MutH.
Mapping the MutH±MutL interaction by cross-linking
Since the interference analysis cannot prove the absence of an interaction between the modi®ed MutH variant and MutL we performed site-speci®c UV crosslinking to probe the proximity of amino acids in MutH to MutL. Therefore we modi®ed the MutH variants with the photoreactive cross-linker benzophenone-4-maleimide and subsequently incubated the modi®ed variant with or without irradiation by UV light (354 nm). The reaction mixtures were analyzed on SDS±PAGE followed by Coomassie staining. Whereas the MutH variant R172C;C96S was able to form a crosslink with MutL to form a species of M r » 100 000 which corresponds to a 1:1 complex between MutL (M r = 70 000) and MutH (M r = 27 700) (Fig. 6 ), the variants S104C;C96S; V166C;C96S and L167C;C96S were not able to do so. No crosslinks were observed without irradiation, with MutH in the absence of MutL, or with MutL in the absence of MutH (data not shown).
DISCUSSION
The identi®cation of speci®c amino acid residues involved in protein±protein interaction is fundamental to understanding structure±function relationships. In this study we wanted to map the binding site of MutH for its activator protein MutL by introducing more or less bulky modi®cations at selected positions on the surface of MutH and determining their interference with MutL activation of MutH. Guided by the structure of MutH and a sequence alignment of MutH proteins we generated 12 variants of MutH containing a single cysteine residue located at strategic positions on the surface of the protein (Fig. 2) . All variants displayed a normal activity in vivo (Table 1) . Due to the fact that the number of proteins expressed from the plasmid are probably much higher than in a wild type cell, a 10-fold reduction in activity of MutH is unlikely to be detected (21) . Our in vitro data on the MutLstimulated activity of MutH, however, revealed that none of the variants was reduced in activity more than by a factor of 1.5 (Table 2) . Therefore, we conclude that the amino acid exchanges did not interfere with the function of the protein in mismatch repair and that our selection of positions to be modi®ed is reasonable.
Next we modi®ed all the MutH variants with thiol speci®c reagents, i.e. N-ethylmaleimide,¯uorescein-5-maleimide and mPEG-MAL 5000. The pegylated MutH variants could be quantitatively separated from excess reagent and unmodi®ed 
S9C;C96S MutH protein by gel ®ltration chromatography as shown by a SDS±PAGE analysis (Fig. 4) . It should be noted that the degree of pegylation shows some dependence on the site of the cysteine residues that were modi®ed and, therefore, the puri®cation by gel ®ltration chromatography was crucial to get >95% modi®ed variants as judged by SDS±PAGE. The modi®ed variants of MutH were tested for endonuclease activity in the absence and presence of the activator protein MutL (Table 3) . Most of the variants displayed only small changes (<2-fold) in endonuclease activity upon modi®cation. However, there are a few exceptions: the pegylated variants S104C;C96S, V166C;C96S, L167C;C96S and to a lesser extent R172C;C96S showed a signi®cant interference with MutL-stimulation of cleavage activity compared with the unmodi®ed variants. When modi®ed with the smaller probē uorescein these variants showed interferences in the order L167C;C96S > V166C;C96S > S104C;C96S > R172C;C96S » C96S. It should be noted that the variants V166C;C96S and L167C;C96S were made as a result of an initial interference study with the other 10 variants. Since the endonuclease activity of these modi®ed variants in the absence of MutL was not changed, we concluded that these residues are part of the protein interaction site for MutL. This conclusion is strengthened by our structure±activity analysis of the modi®ed variants (Fig. 5) . The positions of the modi®ed amino acid residues with the highest effect on MutLstimulated endonuclease activity map to one region of MutH, a region that only slightly overlaps with the hitherto proposed protein interaction site of MutH for MutL based on a docking model (12, 20) . Moreover, the UV crosslink between the benzophenone-4-maleimide modi®ed MutH variant R172C:C96S with MutL, indicates proximity between Arg-172 of MutH and residues of MutL. The absence of UV crosslinks between MutL and other benzophenone-4-maleimide-modi®ed variants can be interpreted either as due to an absence of proximity of these residues to residues in MutL or due to an interference of the modi®cation with interaction to MutL. The second possibility could be true for the three variants S104C;C96S, V166C;C96S and L167C;C96S since these variants displayed interference in activation by MutL upon modi®cation with¯uorescein-5-maleimide, which has a similar radius of action as benzophenone-4-maleimide.
Our analysis will be extended to study also the interaction between MutH and MutS. Furthermore, we are currently generating a cysteine-free variant of MutL and will conduct a similar analysis with MutL as described here for MutH. Since MutL has been shown to interact with several other proteins beside MutH, e.g., MutS (36), UvrD (16) and Vsr (37) , such an analysis will further our understanding of the molecular basis of mismatch repair.
